Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Appl Microbiol ; 120(3): 790-804, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26759117

RESUMEN

AIMS: To investigate the effect of heme, cobalt-protoporphyrin IX and tin-protoporphyrin IX (CoPPIX and SnPPIX), macrocyclic structures composed by a tetrapyrrole ring with a central metallic ion, on Dengue Virus (DENV) and Yellow Fever Virus (YFV) infection. METHODS AND RESULTS: Treatment of HepG2 cells with heme, CoPPIX and SnPPIX after DENV infection reduced infectious particles without affecting viral RNA contents in infected cells. The reduction of viral load occurs only with the direct contact of DENV with porphyrins, suggesting a direct effect on viral particles. Previously incubation of DENV and YFV with heme, CoPPIX and SnPPIX resulted in viral particles inactivation in a dose-dependent manner. Biliverdin, a noncyclical porphyrin, was unable to inactivate the viruses tested. Infection of HepG2 cells with porphyrin-pretreated DENV2 results in a reduced or abolished viral protein synthesis, RNA replication and cell death. Treatment of HepG2 or THP-1 cell lineage with heme or CoPPIX after DENV infection with a very low MOI resulted in a decreased DENV replication and protection from death. CONCLUSIONS: Heme, CoPPIX and SnPPIX possess a marked ability to inactivate DENV and YFV, impairing its ability to infect and induce cytopathic effects on target cells. SIGNIFICANCE AND IMPACT OF THE STUDY: These results open the possibility of therapeutic application of porphyrins or their use as models to design new antiviral drugs against DENV and YFV.


Asunto(s)
Antivirales/farmacología , Virus del Dengue/efectos de los fármacos , Dengue/virología , Hemo/farmacología , Metaloporfirinas/farmacología , Protoporfirinas/farmacología , Fiebre Amarilla/virología , Virus de la Fiebre Amarilla/efectos de los fármacos , Antivirales/química , Dengue/tratamiento farmacológico , Virus del Dengue/genética , Virus del Dengue/fisiología , Hemo/química , Humanos , Metaloporfirinas/química , Protoporfirinas/química , ARN Viral/genética , Inactivación de Virus/efectos de los fármacos , Fiebre Amarilla/tratamiento farmacológico , Virus de la Fiebre Amarilla/genética , Virus de la Fiebre Amarilla/fisiología
2.
Sci Adv ; 6(2): eaaw6284, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-31950075

RESUMEN

Zika virus (ZIKV) infection during pregnancy is associated with a spectrum of developmental impairments known as congenital Zika syndrome (CZS). The prevalence of this syndrome varies across ZIKV endemic regions, suggesting that its occurrence could depend on cofactors. Here, we evaluate the relevance of protein malnutrition for the emergence of CZS. Epidemiological data from the ZIKV outbreak in the Americas suggest a relationship between undernutrition and cases of microcephaly. To experimentally examine this relationship, we use immunocompetent pregnant mice, which were subjected to protein malnutrition and infected with a Brazilian ZIKV strain. We found that the combination of protein restriction and ZIKV infection leads to severe alterations of placental structure and embryonic body growth, with offspring displaying a reduction in neurogenesis and postnatal brain size. RNA-seq analysis reveals gene expression deregulation required for brain development in infected low-protein progeny. These results suggest that maternal protein malnutrition increases susceptibility to CZS.


Asunto(s)
Desnutrición/complicaciones , Infección por el Virus Zika/congénito , Infección por el Virus Zika/complicaciones , Animales , Animales Recién Nacidos , Peso Corporal , Encéfalo/enzimología , Encéfalo/patología , Brasil/epidemiología , Dieta con Restricción de Proteínas , Brotes de Enfermedades , Embrión de Mamíferos/patología , Femenino , Regulación del Desarrollo de la Expresión Génica , Desnutrición/virología , Ratones Endogámicos C57BL , Microcefalia/complicaciones , Microcefalia/virología , Neurogénesis , Tamaño de los Órganos , Embarazo , Síndrome , Carga Viral , Infección por el Virus Zika/virología
3.
Curr Pharm Des ; 24(20): 2311-2316, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30051776

RESUMEN

BACKGROUND: Heme-oxygenase (HO) catalyzes the main enzymatic step of heme degradation and generates anti-inflammatory end products with protective roles in physiological and pathological situations. The importance of HO in pathological conditions is evidenced by its pharmacological inhibition or genetic blockage in different models of stress such as infection, inflammation and oxidative stress. Under these situations, another well-known protective process triggered is autophagy. Autophagy is a homeostatic process that eliminates defective cytosolic components and organelles, allowing cells and tissues to recover through recycling of functional blocks for anabolic reactions. Recently, studies have demonstrated a link between HO activity and autophagy activation. OBJECTIVE: In this review, we focus on the interplay between HO and autophagy, and highlight its importance in homeostasis maintenance under stress conditions.


Asunto(s)
Autofagia/fisiología , Hemo-Oxigenasa 1/metabolismo , Homeostasis/fisiología , Animales , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Humanos , Estrés Fisiológico
4.
Mucosal Immunol ; 8(5): 1154-65, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25712805

RESUMEN

Macrophage migration inhibitory factor (MIF) is involved in eosinophil biology and in type 2 inflammation, contributing to allergic and helminthic diseases. We hypothesized that MIF participates in the pathogenesis of eosinophilic esophagitis (EoE), an allergic condition characterized by esophageal eosinophilic inflammation. MIF is highly expressed in esophageal mucosa of patients with EoE, compared with gastro-esophageal reflux disease and control patients, where it co-localizes predominantly with eosinophils. In vitro, recombinant MIF promotes human eosinophil chemotaxis, while MIF antagonist and CXCR4 antagonist, AMD3100, revert this effect. In a model of EoE induced by ovalbumin, Mif-deficient mice have reduced inflammation and collagen deposition compared with wild-type (WT) mice. Importantly, treatment of WT mice with anti-MIF or with AMD3100 during the challenge phase prevents accumulation of eosinophils and tissue remodeling. Conversely, recombinant MIF promoted tissue eosinophil inflammation in allergic mice. Together, these results implicate MIF in the pathogenesis of esophageal inflammation and suggest that targeting MIF might represent a novel therapy for EoE.


Asunto(s)
Esofagitis Eosinofílica/inmunología , Eosinófilos/inmunología , Oxidorreductasas Intramoleculares/inmunología , Factores Inhibidores de la Migración de Macrófagos/inmunología , Adolescente , Adulto , Animales , Bencilaminas , Ciclamas , Esofagitis Eosinofílica/genética , Esofagitis Eosinofílica/patología , Esofagitis Eosinofílica/terapia , Eosinófilos/patología , Femenino , Compuestos Heterocíclicos/farmacología , Humanos , Oxidorreductasas Intramoleculares/genética , Factores Inhibidores de la Migración de Macrófagos/genética , Masculino , Ratones , Ratones Noqueados , Persona de Mediana Edad , Membrana Mucosa/inmunología , Membrana Mucosa/patología , Receptores CXCR4/antagonistas & inhibidores , Receptores CXCR4/genética , Receptores CXCR4/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA